Keyphrases
Chemokines
100%
Human Cytomegalovirus
100%
N-terminus
100%
CX3C
100%
US28
100%
Carbon Tetrachloride
37%
Chemokine Receptor
25%
Tight-binding
12%
Systemic Disease
12%
C-C Chemokine Receptor Type 5 (CCR5)
12%
High Affinity
12%
Double Approach
12%
Chemokine Binding
12%
Intracellular Signaling
12%
Secondary Modification
12%
Loop Region
12%
Immunocompromised Patients
12%
Fractalkine
12%
G Protein-coupled Receptor
12%
Receptor-ligand Interaction
12%
Ligand Recognition
12%
Vascular Pathology
12%
Dimerization
12%
Glycosaminoglycans
12%
Causative Agents
12%
High-affinity Binding
12%
Receptor Activation
12%
Life-threatening
12%
Risk Factors
12%
Aromatic Residues
12%
CCR1
12%
Cytomegalovirus Infection
12%
Immunocompetent Individual
12%
Two-state Model
12%
Molecular Interactions
12%
Sulfation
12%
Amino Acids
12%
Immunology and Microbiology
Chemokine
100%
Amino Terminal Sequence
100%
CX3C Chemokine
100%
Beta Chemokine
100%
Human cytomegalovirus
100%
Dimerization
20%
Binding Affinity
20%
Amino Acid
20%
Cytomegalovirus Infection
20%
Molecular Interaction
20%
Fractalkine
20%
Atherosclerosis
20%
Immunocompromised Patient
20%
Chemokine Receptor CCR1
20%
CCR5
20%
Chemokine Receptor
20%
Sulfation
20%
Pharmacology, Toxicology and Pharmaceutical Science
CX3C Chemokine
100%
Receptor
100%
Chemokine
100%
Beta Chemokine
100%
Human cytomegalovirus
100%
Atherosclerosis
20%
Cytomegalovirus Infection
20%
Immunocompromised Patient
20%
Vascular Disease
20%
Fractalkine
20%
G Protein Coupled Receptor
20%
Chemokine Receptor
20%
Systemic Disease
20%
Amino Acid
20%
Chemokine Receptor CCR1
20%
Glycosaminoglycan
20%